Genetic studies, clinical heterogeneity, and disease outcome studies in rheumatoid arthritis

Rheumatic Disease Clinics of North America

Volumn 28, Issue 1, 2002, Pages 39-58

  Moxley, George ^a,b   Cohen, Harley J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BONE EROSION; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0036154886     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(03)00068-1     Document Type: Review

References (117)

1. Compound heterozygosity of HLA-DR4 and DR1 antigens in Asian Indians increases the risk of extra-articular features in rheumatoid arthritis
2. DR antigen distribution in Blacks with rheumatoid arthritis
3. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis
4. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
5. Genetic analysis of multiplex rheumatoid arthritis families
6. Risk factors for radiographic articular destruction of hands and wrists in rheumatoid arthritis
7. HLA-DRB1 alleles associated with rheumatoid arthritis in Southern France. Absence of extraarticular disease despite expression of the shared epitope
8. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients
9. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks: The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients
10. TNF alpha - A pivotal role in rheumatoid arthritis?
11. Tumour necrosis factor a gene polymorphisms in rheumatoid arthritis: Association with susceptibility to, or severity of, disease?
12. Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage
13. Inheritance of the shared epitope and long-term outcomes of rheumatoid arthritis among community-based Caucasian females
14. Relevant residues of DRβ1 third hypervariable region contributing to the expression and to severity of rheumatoid arthritis (RA) in Mexicans
15. Ancestral haplotypes: Conserved population MHC haplotypes
16. Both inherited HLA-haplotypes are important in the predisposition to rheumatoid arthritis
17. HLA-DRB1 alleles associated with susceptibility or resistance to rheumatoid arthritis, articular deformities, and disability in Mexican Americans
18. Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: Rejection of the unifying-shared-epitope hypothesis
19. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis
20. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis - Their relation to disease progression
21. Association of HLA alleles and clinical features in patients with synovitis of recent onset
22. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
23. Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis
24. The genotypic distribution of shared-epitope DRB1 alleles suggests a recessive mode of inheritance of the rheumatoid arthritis disease-susceptibility gene
25. HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis
26. Rheumatoid arthritis in Israeli Jews: Shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility
27. Influence of the HLA-DR beta shared epitope on susceptibility to and clinical expression of rheumatoid arthritis in Chilean patients
28. Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis
29. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
30. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
31. Racial origin and its effect on disease expression and HLA-DRB1 types in patients with rheumatoid arthritis: A matched cross-sectional study
32. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients
33. HLA markers in a community-based rheumatoid arthritis series
34. The natural course of gold and penicillamine nephropathy: A long-term study of 54 patients
35. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis
36. The association of HLA-DRB genes and the shared epitope with rheumatoid arthritis in Pakistan
37. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis
38. HLA-linked rheumatoid arthritis
39. Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid
40. A re-analysis of the association between rheumatoid arthritis with and without extraarticular features, HLA-DR4, and DR4 subtypes
41. Predicting the prognosis of patients with rheumatoid arthritis: Is there a crystal ball?
42. HLA and rheumatoid arthritis: A combined analysis of 440 British patients
43. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis
44. The impact of HLA-DRB1*0405 on disease severity in Korean patients with seropositive rheumatoid arthritis
45. Association of HLA-DRB1*0405 with extraarticular manifestations and erosions in Singaporean Chinese with rheumatoid arthritis
46. TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis
47. HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients
48. HLA-DR genotype risks in seropositive rheumatoid arthritis
49. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset, and disease severity
50. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis
51. Clinical expression of rheumatoid arthritis in Chilean patients
52. Weak association between HLA-DR4 and rheumatoid arthritis in Chilean patients
53. The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis
54. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis - Influence on disease outcome
55. Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope)
56. A multicase family study of rheumatoid arthritis in south west Ireland
57. Major histocompatibility complex variants and articular disease severity in rheumatoid arthritis
58. Tumor necrosis factor markers show sex-influenced association with rheumatoid arthritis
59. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis
60. Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis
61. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
62. Association of the shared epitope with radiological severity of rheumatoid arthritis
63. Relative predispositional effects and mode of inheritance of HLA-DRB1 alleles among community-based Caucasian females with rheumatoid arthritis
64. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis
65. Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in women with recent-onset rheumatoid arthritis
66. Rheumatoid arthritis
67. Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis
68. HLA-DRB1 typing in rheumatoid arthritis: Predicting response to specific treatments
69. Prognostic significance of complement alleles Bf and C 4 in early rheumatoid arthritis
70. Association of complement alleles C4AQ0 and C4B5 with rheumatoid arthritis in Koreans
71. Does the age of onset of rheumatoid arthritis influence phenotype: A prospective study of outcome and prognostic factors
72. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis
73. Patterns of radiological progression in early rheumatoid arthritis: Results of an 8 year prospective study
74. Seronegative and weakly seropositive rheumatoid arthritis differ from clearly seropositive rheumatoid arthritis in HLA class II associations
75. Familial vs sporadic rheumatoid arthritis (RA). A prospective study in an early RA inception cohort
76. The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis
77. HLA-DRB1 genes and disease severity in rheumatoid arthritis
78. Investigating the HLA component in rheumatoid arthritis: An additive (dominant) mode of inheritance is rejected, a recessive mode is preferred
79. The effect of HLA-DRB1 disease susceptibility markers on the expression of RA
80. HLA-DRB1 alleles associated with rheumatoid arthritis in Northern Italy: Correlation with disease severity
81. HLA-DO-related restriction fragment length polymorphisms in rheumatoid arthritis: Evidence for a link with disease expression
82. Association between HLA-DR antigens and rheumatoid arthritis in Arabs
83. Histocompatibility antigens (A, B, Cand DR) in Arabs with rheumatoid arthritis
84. Association of (Q)R/KRAA positive HLA-DRB1 alleles with disease progression in early active and severe rheumatoid arthritis
85. HLA-DRB1*04 subtypes are associated with increased inflammatory activity in early rheumatoid arthritis
86. HLA-DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestations
87. Only weak association between disease severity and HLA-DRB1 genes in a Swiss population of rheumatoid arthritis patients
88. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis
89. Mixed lymphocyte cultures in rheumatoid arthritis
90. HLA-DRB1 alleles in Greek rheumatoid arthritis patients and their association with clinical characteristics
91. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study
92. Positive and negative association of HLA-DR genotypes with Japanese rheumatoid arthritis
93. Susceptibility epitope on HLA-DR beta chain for rheumatoid arthritis and the effect of the positivity on the clinical features
94. A retrospective study using nail clippings of rheumatoid susceptible alleles of HLA-DRB1 as a prognostic factor in early rheumatoid arthritis
95. HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: The "shared epitope" hypothesis may not apply
96. Relationship between duration of rheumatoid arthritis before knee joint surgery and HLA-DRB1 alleles: A retrospective study
97. Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA
98. HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from Eastern France with rheumatoid arthritis
99. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study
100. HLA class II and T-cell receptor beta chain polymorphisms in Belgian patients with rheumatoid arthritis: No evidence for disease association with the TCRBC2, TCRBV8 and TCRBV11 polymorphisms
101. Association of HLA-DR with susceptibility to and clinical expression of rheumatoid arthritis: Re-evaluation by means of genomic tissue typing
102. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis: Results of a follow up study
103. Heat shock protein 70 gene polymorphisms in rheumatoid arthritis
104. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis
105. An association between the natural course of shoulder joint destruction in rheumatoid arthritis and HLA-DRB1́0405 in Japanese patients
106. The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese
107. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
108. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis
109. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
110. The influence of sex on the phenotype of rheumatoid arthritis
111. Meta-analysis reveals association between most common class II haplotype in full-heritage Native Americans and rheumatoid arthritis
112. A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis
113. HLA DRB1* typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis
114. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan
115. Association of HLA-DR4/Dw4 and DR2/Dw 2 with radiologic changes in a prospective study of patients with rheumatoid arthritis
116. A prognostic index for erosive changes in the hands, feet, and cervical spines in early rheumatoid arthritis